Home
Up
NCS - Allergic Alveolitis
Bacterial Diseases
NCS - Conjunctivitis
NCS - Giardia Infections
NCS - Giardia in Cockatiels
NCS - Psittacosis 2
NCS - Psittacosis 1
NCS - Psittacosis 3
NCS - Psittacosis 2
NCS - Psittacosis in Tiels
NCS - Polyoma
NCS - Heavy Metal Poisoning
Exotic Newcastle
NCS - Ecoli and Bacteria
Bumblefoot   

PART III. 
Epidemiologic Investigations

Copyright Notice & Disclaimer Statement


Epidemiologic investigations may be necessary to assist in controlling the transmission of C. psittaci in birds and humans. An epidemiologic investigation should be initiated if:

  1. a bird that has confirmed or probable AC was procured from a pet store, breeder, or dealer within 60 days of the onset of its signs

  2. a human has confirmed or probable psittacosis, or

  3. there are several suspect avian cases from the same source

Other situations may be investigated at the discretion of the appropriate local or state public or animal health authorities.

Investigations involving recently purchased birds should include a visit to the site where the infected bird is located and identification of the location where the bird was originally procured (e.g., pet shops, dealers, breeders, and quarantine stations). In conducting investigations, important considerations may include documenting the number and type(s) of birds involved, the health status of potentially affected persons and birds, locations of facilities where birds were housed, relevant ventilation-related factors, the treatment protocol, and the source of medicated feed, if such treatment is initiated. To facilitate identification of multistate outbreaks of C. psittaci infection, local and state authorities should report suspected outbreaks to the Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, CDC, telephone (404) 639-2215.

 


References

1. Us Department of Agriculture, Animal and Plant Health Inspection Service. Importation of certain animals, birds, and poultry and certain animal, bird and poultry products: requirements for means of conveyance and shipping containers. CFR Title 9 Part 92. 101-7, Jan. 1, 1997.
2. CDC. Summary of notifiable diseases, United States, 1995. MMWR 1995;44(53):74-7.
3. CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10):27.

Additional Information
Flammer K. Chlamydia In: Altman RB, Clubb SL, Dorrestein GM, Quesenberry K, eds. Avian Medicine and Surgery. Philadelphia: W.B. Saunders Co., 1997:364- 79.
Fudge AM. Avian chlamydiosis. In: Rosskopf WJ, Woerpel RW, eds. Diseases of cage and aviary birds. Baltimore: Williams & Wilkins, 1996:572-85.
Gelach H. Chlamydia. In: Ritchie BW, Harrison GJ, Harrison LR, eds. Avian medicine, principles and applications. Lake Worth, FL: Wingers Publishing, 1994:984-96.
Schlossberg D. Chlamydia psittaci (psittacosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease, 4th ed. New York: CHurchill Livingstone, 1995:1693-6.
Schaffner W. Birds of a feather--do they flock together? Infect Control Hosp Epidemiol 1997;18:162-4.


Appendix A - Diagnostic Methods For Avian Chlamydiosis

Histopathologic Findings

In birds that have avian chlamydiosis (AC), cloudy air sacs and enlarged liver and spleen are usually observed, but no specific, gross lesion is pathognomonic. The chromatic or immunologic staining of tissue-impression smears can be used to identify organisms.

Culture Technique

Isolation of the etiologic agent, Chlamydia psittaci, from spleen, liver, air sacs, pericardium, heart, or intestines is the optimal diagnostic verification. Chlamydia organisms are obligate intracellular bacteria that must be isolated in tissue culture, mice, or chick embryos. Specialized laboratory facilities and training are necessary both for reliable identification of chlamydial isolates and for protection of the microbiologists. Consequently, few laboratories perform chlamydial cultures.

In live birds, depending on which clinical signs they exhibit, combined cloacal and choanal-swab specimens should be collected, refrigerated, and sent to the laboratory packed in ice, but not frozen. The proper handling of samples is critical for maintaining the viability of organisms for culture, and a special transport medium is required. Veterinarians should contact their specific diagnostic laboratory for procedures required for submission of specimens for isolation.

Live birds being screened for C. psittaci may not shed the microorganism daily. Therefore, to reduce laboratory costs, serial specimens should be collected for 3-5 consecutive days and pooled before being cultured. Tissue samples from the liver and spleen are the preferred necropsy specimens for isolation of C. psittaci. When legal actions may result from chlamydiosis cases, use of culture is recommended to avoid limitations associated with other tests.

Tests for Antibody

A major problem with serologic testing is the interpretation of results. A positive serologic test result is evidence that the bird was infected by C. psittaci in the past, but it does not prove that the bird currently has active disease. False-negative results may occur for birds that have acute infection when they are sampled before seroconversion. Antibiotic treatment may diminish the antibody response.

A single testing method may not be adequate because of the diversity of reactions with immunoglobulins from the various avian species. Therefore, the use of a combination of antibody- and antigen-detection methods for the diagnosis of chlamydiosis is recommended, particularly when only one bird is tested. When specimens are obtained from a single bird, serologic testing is most useful when

  1. signs of disease and the history of the flock or aviary are considered and

  2. serological results are compared with the white blood cell counts and liver-enzyme activities. Either a greater than fourfold increase in titer of paired samples or a combination of a titer and antigen identification is needed to confirm a diagnosis of chlamydiosis.

Some of the advantages/disadvantages of several of the serologic tests for antibodies are as follows:

Direct Complement Fixation (CF) Test

Direct CF is more sensitive to antibody activity than are agglutination methods. No commercial antigen is available. False-negative results are possible in specimens from small psittacine birds (e.g., budgerigars, young African grey parrots, and lovebirds). High titers may persist after treatment and complicate interpretation of subsequent tests. Modified direct CF is more sensitive than direct CF.

Elementary-Body Agglutination (EBA)

EBA is commercially available and can detect early infection. Titers >10 in budgerigars, cockatiels, and lovebirds and titers of >20 in larger birds are interpreted by the laboratory as indicating current infection. However, positive titers may persist after treatment is completed, and EBA is performed only by a single laboratory.

Tests for Antigen

Immunofluorescent-Staining Tests (fluorescent antibody)

Monoclonal or polyclonal antibodies, fluorescein-staining techniques, and fluorescent microscopy are used to identify elementary bodies (i.e., infectious agents) in impression smears from dead birds. When used with cloacal or fecal smears, the test sensitivity and specificity are questioned by some authorities. The test is most useful if the bird is shedding antigen. Its advantages are that it gives rapid results and does not require live, viable organisms. Laboratory experience is important for accurate interpretation of immunofluorescent stains.

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA tests (i.e., IDEIA®) currently being used to identify C. psittaci were originally developed for identification of the lipopolysaccharide antigen on C. trachomatis, which is a human pathogen. The sensitivity and specificity of these tests for identifying C. psittaci are not precisely known. While the test is most useful in clinically ill birds, the sensitivity may be low in asymptomatic birds because of intermittent shedding. Moreover, some tests may be falsely positive because of cross-reaction with other bacteria. The test results must be evaluated in conjunction with other clinical findings. If a bird has a positive ELISA result but is clinically healthy, the veterinarian should attempt to verify that the bird is shedding antigen through isolation of the organism. When a clinically ill bird has a negative ELISA result, a diagnosis of AC cannot be excluded without further testing (e.g., isolation, serologic testing, or fluorescent antibody).

Additional Tests

Additional diagnostic techniques are in use or under development, including polymerase chain reaction (PCR). Readers are encouraged to research pre-reviewed reports on such tests prior to use.

Laboratories that Provide AC Testing

Many state diagnostic laboratories and veterinary colleges perform routine chlamydial diagnostics. Additional laboratories are listed below; others may be available. Inclusion in this list does not imply endorsement from the Psittacosis Compendium.

 

California Avian Laboratory

800-783-2473

FA

Labcorp Veterinary Services

800-334-5161

Culture

Marshfield Laboratories

800-222-5835

Culture, EBA (TX), CF (TX)

Avian and Exotic Animal Laboratories

310-542-6556

PCR, DC (TX)

Animal Health Diagnostic Laboratory

517-353-1683

EIA (Unipath), PCR, CF (Ames)

Texas Veterinary Medical Laboratory

409-845-3414

Culture, PCR, EBA, CF

Comparative Pathology Laboratory

600-596-7390

IFA serology, EIA (Unipath)

Research Associates Laboratory

513-248-4700

PCR

Return to Psittacosis Index

 


Appendix B - Chlamydiosis Treatment Options For Companion Birds

Veterinarians can choose several methods for treating avian chlamydiosis (AC). Although these protocols are usually successful, knowledge in this area is evolving, and no treatment protocol guarantees safe treatment or complete elimination of infection by the etiologic agent Chlamydia psittaci in all avian species. Therefore, treatment should be supervised by a licensed veterinarian.

Methods of Treatment

Several methods of treating AC exist. All birds should be treated for a period of 45 days, except as noted below. The following are established as effective treatments:

Medicated Feed

The medicated feed should be the only food provided to the birds during the entire treatment. Birds' acceptance of medicated feed is variable. Thus, food consumption should be monitored. Acceptance may be enhanced by first adapting the birds to a similar, nonmedicated diet. The treatment begins when the birds accept the medicated feed as the sole food in their diet.

  1. Medicated mash diets (i.e., >1% chlortetracycline [CTC] with <0.7% calcium) prepared with corn can be used.*

  2. White millet seed, impregnated with 0.5 mg CTC/g of seed, may be used for budgerigar parakeets and finches only. It should be used for 30 days (Keet Life®, Hartz Mountain is the only manufacturer).

  3. Pellets and extruded products containing 1% CTC may be used. They are available and appropriate for use in most companion birds. A pellet size should be selected that is appropriate for the size of bird being treated.

  4. A special diet may be necessary for birds belonging to a subfamily of psittacine birds know as Lariidae (i.e., lories and lorikeets) that feed on nectar and fruit in the wild.

    Oral or Parenteral Treatments

    Three such treatments are provided.

    Oral doxycycline. Doxyclycline is the drug of choice for oral treatment; either the monohydrate or calcium-syrup formulations may be used. Based on nonpeer-reviewed studies, dosage recommendations are as follows: 40-50 mg/kg by mouth once a day for cockatiels, Senegal parrots, and blue-fronted and orange-winged Amazon parrots; and 25 mg/kg by mouth once a day for African grey parrots, Goffin's cockatoos, and blue and gold and green-winged macaws. Precise dosages cannot be extrapolated for untested species; however, 25-30 mg/kg administered by mouth once a day is the recommended starting dose in cockatoos and macaws and 25-50 mg/kg by mouth once a day is the recommended starting dose in other psittacine species. If the bird regurgitates the drug, another treatment method should be used.

    Injectable doxycycline. Intramuscular (IM) injection into the pectoral muscle is often the easiest method of treatment, but not all injectable doxycycline formulations are suitable for IM injection. All currently available formulations may cause irritation at the injection site. The Vibrovenos® formulation (Pfizer Laboratories) is available in Europe and Canada and is effective if administered at doese of 75-100 mg/kg IM every 5-7 days for the first 4 weeks and subsequently every 5 days for the duration of the treatment. Anecdotal reports exist of the successful use of pharmacist-compounded injectable-doxycycline products in the United States. However, data are insufficient to determine precise dosage schedules. The injectable-hyclate formulation labeled for intravenous (IV) use in humans in the United States is not suitable for IM use, because severe tissue reactions will occur at the site of injection.

    Injectable oxytetracycline. Limited information exists for the use of an injectable, long-acting oxytetracycline product (LA-200®; Pfizer Laboratories). Current dosage recommendations are as follows: subcutaneous injection of 75 mg/kg every 3 days in Goffin's cockatoos, blue-fronted and orange-winged Amazon parrots, and blue and gold macaws. This dose may be suitable for other species but has not been tested. This product causes irritation at the site of injection and is best used to initiate treatment in ill birds or those that are reluctant to eat. After stabilization with oxytetracycline treatment, the birds should be switched to another form of treatment to reduce the muscle irritation that is caused by repeated oxytetracycline injection.

    Medicated Feed

    Experimental methods

    Treatment protocols using fluoroquinolones, late-generation macrolides, pharmacist-compounded injectable doxycycline, and doxycycline-medicated feed are currently being investigated. Information about these treatment protocols may be available in the scientific literature or from avian veterinary specialists.

    Sources of Medicated Feeds

    These are not listed as an endorsement of said company or products. Other sources may be available.

    Avi-Sci, Inc.; P.O. Box 598; Okemos, MI 48805; 800-942-4800
    The Bird Company; 619-748-3847
    Hartz Mountain Corp.; 700 Frank E. Rogers Blve; Harrison, NJ 07029; 201-481-4800
    Lafeber Company; RR 2; Odell, IL 60460; 800-842-6445
    Kaytee Products, Inc.; P.O. Box 230; 292 East Grand St.; Chilton, WI 53014; 800-669-9580; 800-356-5020
    Pretty Bird International, Inc.; 5810 Stacy Trail; Stacy MN 55079; 800-356-5020
    Rolf C. Hagen; P.O. Box 9107; Mansfield, MA 02048; 800-225-2700/2701
    Roudybush; P.O. Box 908; Templeton, CA 93465; 800-326-1726; 805-434-0303
    Ziegler Brothers, Inc.; P.O. Box 95; Gardners, PA 17324-0095; 800-841-6800


    *The recommended recipe is 2 pounds of rice, 2 pounds of hen scratch feed, and 3 pints of water, cooded for 15 minutes at full pressure in a pressure cooker. Add 10 mg chlortetracycline/g of feed after the cooked feed cools. Note that birds may find this diet unpalatable and may not accept it.


    Home ] Avian Diseases ] NCS - Behavior Libary ] Breeding Libary ] Healthcare Libary ] Cockatiel Clinic ] Color Mutations ] Nutrition Libary ]